86367440 - GWPCARE CANNABIDIOL IN RESISTANT EPILEPSY

Information

• Trademark
• 86367440

• Source

• Serial Number

  86367440

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 16 - Paper, cardboard and goods made from these materials, not included in other classes
  • 31 - Grains and agricultural, horticultural and forestry products not included in other classes
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  August 14, 2014
  10 years ago

• Transaction Date

  April 18, 2017
  7 years ago

• Status Date

  May 23, 2016
  8 years ago

• Published for Opposition Date

  August 25, 2015
  9 years ago

• Location Date

  October 20, 2015
  9 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  STRUCK, ROBERT J

• Attorney Name

  Michelle L. Visser

  Law Office Assigned Location Code

  L90

• Owners

  • GW Pharma Limited

Case File Statements

• CC0000: The color(s) green and blue is/are claimed as a feature of the mark.
• D10000: "CANNABIDIOL IN RESISTANT EPILEPSY"
• DM0000: The mark consists of the stylized wording "GWP CARE CANNABIDIOL IN RESISTANT EPILEPSY". The wording "GWP" appears in green in the upper left. The wording "CARE" appears in the upper right in blue. The wording "CANNABIDIOL IN RESISTANT EPILEPSY" appears in blue below the wording "GWP CARE".
• GS0051: Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; veterinary preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, spasticity, convulsions, seizures, epilepsy, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, obesity, obesity associated with diabetes; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; sanitary preparations for medical purposes; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes; all of the foregoing containing cannabidiol
• GS0091: Computer programmes for collection, editing, organizing, modifying, managing, transmission, storage and sharing of data and information for use in relation to clinical trials, educational matters and pharmaceutical preparations and substances; computer software for collection, editing, organizing, modifying, managing, transmission, storage and sharing of data and information for use in relation to clinical trials, educational matters and pharmaceutical preparations and substances; data processing apparatus; pre-recorded optical discs featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances; information stored on electronic, magnetic and/or by optical means, namely, audio and video recordings featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances; downloadable electronic publications in the nature of books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances; electronic teaching publications in the nature of books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances
• GS0101: Surgical, medical, dental and veterinary apparatus, instruments and implements, namely, drug delivery systems; applicators for pharmaceutical preparations, namely, drug delivery systems; drug inhalation devices, namely, inhalers and nebulizers for medical purposes; apparatus for drug administration, namely, drug delivery systems; drug delivery devices, namely, medical syringes, and transdermal patches sold without medication; structural parts and fittings for all of the aforesaid goods
• GS0161: Paper; printed matter, namely, books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational matter and pharmaceutical preparations and substances; packing materials of paper or cardboard; wrapping paper; packaging boxes of paper, paperboard or cardboard; stationery; photographs; printed instructional and teaching material in the field of clinical trials, educational and pharmaceutical preparations and substances; printed teaching and instructional material for research on health, drugs, pharmaceuticals, medical and technical laboratory matters
• GS0311: Agricultural seeds; flowers; live plants
• GS0411: Educational services, namely, classes, seminars and workshops in the fields of clinical trials, educational matters and pharmaceutical preparations and substances; tuition training services in the field of clinical trials; provision of training and instruction services in the field of clinical trials, educational and pharmaceutical preparations and substances; publication of books and texts; publishing of electronic publications provision of online electronic publications in the nature of books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational matter and pharmaceutical preparations and substances; arranging and conducting symposiums, conferences, congresses and exhibitions for educational purposes in the field of clinical trials, educational matter and pharmaceutical preparations and substances; advisory, information and consultancy services relating to all of the aforesaid
• GS0421: Scientific and technological services, namely, scientific and technological research services relating to clinical trials and pharmaceutical preparations and substances; scientific research services; design services in the field of clinical trials and pharmaceutical preparations and substances; industrial design services; computer programming services; technical and scientific consultancy and research services in the field of clinical trials and pharmaceutical preparations and substances; testing and analysis of pharmaceutical preparations and substances; computerised analysis of scientific data; scientific laboratory services in the field of clinical trials and pharmaceutical preparations and substances; industrial analysis and research services in the field of clinical trials and pharmaceutical preparations and substances; medical research relating to epilepsy; analysis of medical research relating to epilepsy; chemical analysis services; chemical, biological, biotechnology and biomedical research services; research and development services in the field of clinical trials and pharmaceutical preparations and substances; conducting clinical trials for others; clinical research, namely, scientific research; providing medical research clinical trial information via a website; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; advisory, information and consultancy services relating to all of the aforesaid
• GS0441: Medical services; healthcare services; veterinary services; medical analysis services, namely, medical consultations; horticultural services; provision of pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals via the internet; providing medical information on the internet; advisory, information and consultancy services relating to all of the aforesaid
• PM0001: GWP CARE CANNABIDIOL IN RESISTANT EPILEPSY

Case File Event Statements

• 5/23/2016 - 8 years ago

  30 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6

• 5/23/2016 - 8 years ago

  29 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 10/20/2015 - 9 years ago

  28 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 8/25/2015 - 9 years ago

  27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/25/2015 - 9 years ago

  26 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/5/2015 - 9 years ago

  25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 7/17/2015 - 9 years ago

  24 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 7/16/2015 - 9 years ago

  23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/13/2015 - 9 years ago

  22 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 7/13/2015 - 9 years ago

  21 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 7/13/2015 - 9 years ago

  20 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 7/13/2015 - 9 years ago

  19 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 6/22/2015 - 9 years ago

  18 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 6/18/2015 - 9 years ago

  17 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 6/18/2015 - 9 years ago

  16 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 6/18/2015 - 9 years ago

  15 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 4/20/2015 - 9 years ago

  14 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 4/20/2015 - 9 years ago

  13 - FINAL REFUSAL E-MAILED Type: GNFR

• 4/20/2015 - 9 years ago

  12 - FINAL REFUSAL WRITTEN Type: CNFR

• 3/19/2015 - 9 years ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/19/2015 - 9 years ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/19/2015 - 9 years ago

  9 - ASSIGNED TO LIE Type: ALIE

• 3/11/2015 - 9 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/11/2014 - 10 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/11/2014 - 10 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/11/2014 - 10 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/8/2014 - 10 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 8/27/2014 - 10 years ago

  3 - NOTICE OF PSEUDO MARK E-MAILED Type: MPMK

• 8/26/2014 - 10 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 8/18/2014 - 10 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP